| ASSET | MONTH | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | December 2023 | 149% |
Sezzle (SEZL) | December 2023 | 105.41% |
Terawulf (WULF) | December 2023 | 101.68% |
Aurora Innovation (AUR) | December 2023 | 101.38% |
CleanSpark (CLSK) | December 2023 | 86.63% |
Edgewise Therapeutics (EWTX) | December 2023 | 81.73% |
Arcutis Biotherapeutics (ARQT) | December 2023 | 74.59% |
Compass (COMP) | December 2023 | 71.69% |
Liquidia Technologies (LQDA) | December 2023 | 68.02% |
CommScope (VISN) | December 2023 | 67.86% |
GeneDx (WGS) | December 2023 | 59.88% |
Twist Bioscience (TWST) | December 2023 | 54.74% |
Upstart Holdings (UPST) | December 2023 | 54.31% |
Sunrun (RUN) | December 2023 | 54.08% |
Century Aluminum (CENX) | December 2023 | 53.28% |
Opendoor Technologies (OPEN) | December 2023 | 50.84% |
Viking Therapeutics (VKTX) | December 2023 | 50.08% |
Scholar Rock (SRRK) | December 2023 | 49.44% |
Photronics (PLAB) | December 2023 | 49.38% |
Cipher Mining (CIFR) | December 2023 | 47.5% |
Applied Opt (AAOI) | December 2023 | 46.47% |
Xometry (XMTR) | December 2023 | 45.68% |
Terns Pharmaceuticals (TERN) | December 2023 | 45.52% |
Applied Digital (APLD) | December 2023 | 44.95% |
Apogee Therapeutics, Inc Common Stock (APGE) | December 2023 | 44.69% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
